Proton and Phosphorous MR Spectroscopy in Squamous Cell Carcinomas of the Head and Neck

Academic Radiology

Volumn 16, Issue 11, 2009, Pages 1366-1372

  Chawla, Sanjeev ^a   Kim, Sungheon ^a   Loevner, Laurie A ^a   Quon, Harry ^a   Wang, Sumei ^a   Mutale, Faith ^a   Weinstein, Gregory ^a   Delikatny, Edward J ^a   Poptani, Harish ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

choline; phosphomonoester; phosphorous MR spectroscopy; proton MR spectroscopy; Squamous cell carcinoma of the head and neck

Indexed keywords

CHOLINE; LACTIC ACID; PHOSPHATASE; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HEAD AND NECK CARCINOMA; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORUS; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70349759381     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.06.001     Document Type: Article

References (53)

1. Funk G.F., Karnell L.H., Robinson R.A., Zhen W.K., Trask D.K., and Hoffman H.T. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer data base report. Head Neck 24 (2002) 165-180
2. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 (2000) 256-263
3. Zorat P.L., Paccagnella A., Cavaniglia G., et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Natl Cancer Inst 96 (2004) 1714-1717
4. Podo F. Tumour phospholipid metabolism. NMR Biomed 12 (1999) 413-439
5. McKenna W.G., Lenkinski R.E., Hendrix R.A., Vogele K.E., and Bloch P. The use of magnetic resonance imaging and spectroscopy in the assessment of patients with head and neck and other superficial human malignancies. Cancer 64 (1989) 2069-2075
6. Maldonado X., Alonso J., Giralt J., et al. 31Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors. Int J Radiat Oncol Biol Phys 40 (1998) 309-312
7. Shukla-Dave A., Poptani H., Loevner L.A., et al. Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Acad Radiol 9 (2002) 688-694
8. Arias-Mendoza F., Smith M.R., and Brown T.R. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad Radiol 11 (2004) 368-376
9. Arias-Mendoza F., Zakian K., Schwartz A., et al. Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies. NMR Biomed 17 (2004) 382-391
10. Gadian D.G., Isaacs E.B., Cross J.H., et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 46 (1996) 974-977
11. Bourne R.M., Stanwell P., Stretch J.R., et al. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Eur J Radiol 53 (2005) 506-513
12. Hollingworth W., Medina L.S., Lenkinski R.E., et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 27 (2006) 1404-1411
13. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4 (1991) 47-52
14. Mukherji S.K., Schiro S., Castillo M., Kwock L., Muller K.E., and Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 18 (1997) 1057-1072
15. Mukherji S.K., and Gerstle R.J. In vitro 1H MR spectroscopy of squamous cell carcinoma of the extracranial head and neck. Neuroimaging Clin N Am 8 (1998) 835-847
16. Bisdas S., Baghi M., Huebner F., et al. In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck. Eur Radiol 17 (2007) 251-257
17. Kuesel A.C., Graschew G., Hull W.E., Lorenz W., and Thielmann H.W. 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed 3 (1990) 78-89
18. Star-Lack J.M., Adalsteinsson E., Adam M.F., et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol 21 (2000) 183-193
19. Gerstle R.J., Aylward S.R., Kromhout-Schiro S., and Mukherji S.K. The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 21 (2000) 1133-1138
20. Maheshwari S.R., Mukherji S.K., Neelon B., et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol 21 (2000) 1930-1935
21. Bezabeh T., Odlum O., Nason R., et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am J Neuroradiol 26 (2005) 2108-2113
22. Christiansen P., Toft P.B., Gideon P., Danielsen E.R., Ring P., and Henriksen O. MR-visible water content in human brain: a proton MRS study. Magn Reson Imaging 12 (1994) 1237-1244
23. Poptani H., Gupta R.K., Roy R., Pandey R., Jain V.K., and Chhabra D.K. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 16 (1995) 1593-1603
24. Mishra A.M., Gupta R.K., Jaggi R.S., et al. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28 (2004) 540-547
25. Vogl T., Peer F., Schedel H., et al. 31P-spectroscopy of head and neck tumors-surface coil technique. Magn Reson Imaging 7 (1989) 425-435
26. Hendrix R.A., Lenkinski R.E., Vogele K., Bloch P., and McKenna W.G. 31P localized magnetic resonance spectroscopy of head and neck tumors-preliminary findings. Otolaryngol Head Neck Surg 103 (1990) 775-783
27. Karczmar G.S., Meyerhoff D.J., Boska M.D., et al. P-31 spectroscopy study of response of superficial human tumors to therapy. Radiology 179 (1991) 149-153
28. Ruiz-Cabello J., and Cohen J.S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5 (1992) 226-233
29. Luyten P.R., Bruntink G., Sloff F.M., et al. Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed 1 (1989) 177-183
30. Li C.W., Negendank W.G., Murphy-Boesch J., Padavic-Shaller K., and Brown T.R. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9 (1996) 141-155
31. Mukherji S.K., Schiro S., Castillo M., et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol 17 (1996) 1485-1490
32. El-Sayed S., Bezabeh T., Odlum O., et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 24 (2002) 766-772
33. Huang W., Roche P., Shindo M., Madoff D., Geronimo C., and Button T. Evaluation of head and neck tumor response to therapy using in vivo 1H MR spectroscopy: correlation with pathology. Proc Int Soc Magn Reson 8 (2000) 552
34. McKnight T.R. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 31 (2004) 605-617
35. Barker P.B., Breiter S.N., Soher B.J., et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 32 (1994) 157-163
36. Albers M.J., Krieger M.D., Gonzalez-Gomez I., et al. Proton-decoupled 31P MRS in untreated pediatric brain tumors. Magn Reson Med 53 (2005) 22-29
37. Usenius J.P., Vainio P., Hernesniemi J., and Kauppinen R.A. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 63 (1994) 1538-1543
38. Smith T.A., Glaholm J., Leach M.O., Machin L., and McCready V.R. The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed 4 (1991) 262-267
39. Aboagye E.O., and Bhujwalla Z.M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59 (1999) 80-84
40. Cai H., Erhardt P., Troppmair J., et al. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol Cell Biol 13 (1993) 7645-7651
41. Daly P.F., Lyon R.C., Faustino P.J., and Cohen J.S. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J Biol Chem 262 (1987) 14875-14878
42. Miceli M.V., Kan L.S., and Newsome D.A. Phosphorus-31 nuclear magnetic resonance spectroscopy of human retinoblastoma cells: correlation with metabolic indices. Biochim Biophys Acta 970 (1988) 262-269
43. Bruhn H., Frahm J., Gyngell M.L., et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172 (1989) 541-548
44. Kinoshita Y., Yokota A., and Koga Y. Phosphorylethanolamine content of human brain tumors. Neurol Med Chir (Tokyo) 34 (1994) 803-806
45. Clejan S. HPLC analytical methods for the separation of molecular species of fatty acids in diacylglycerol and cellular phospholipids. Methods Mol Biol 105 (1998) 255-274
46. Kalra R., Wade K.E., Hands L., et al. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Br J Cancer 67 (1993) 1145-1153
47. Maris J.M., Evans A.E., McLaughlin A.C., et al. 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. N Engl J Med 312 (1985) 1500-1505
48. Kinoshita Y., and Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10 (1997) 2-12
49. Dixon R.M., and Tian M. Phospholipid synthesis in the lymphomatous mouse liver studied by 31P nuclear magnetic resonance spectroscopy in vitro and by administration of 14C-radiolabelled compounds in vivo. Biochim Biophys Acta 1181 (1993) 111-121
50. Cullis P.R., de Kruijff B., Hope M.J., Nayar R., and Schmid S.L. Phospholipids and membrane transport. Can J Biochem 58 (1980) 1091-1100
51. Kiss Z., Crilly K.S., and Anderson W.H. Carcinogens stimulate phosphorylation of ethanolamine derived from increased hydrolysis of phosphatidylethanolamine in C3H/101/2 fibroblasts. FEBS Lett 336 (1993) 115-118
52. Gillham H., and Brindle K.M. 31P NMR measurements of the effects of unsaturated fatty acids on cellular phospholipid metabolism. Magn Reson Med 35 (1996) 481-488
53. Smith T.A., Glaholm J., Leach M.O., et al. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 63 (1991) 514-516